Trials / Completed
CompletedNCT03693547
Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）
Open, Multicenter, Monotherapy, Phase II Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer After Failure or Intolerability to Second-line Standard Treatment
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To assess the effectiveness and safety of utidelone injection in patients with advanced or metastatic NSCLC as a phase II trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | utidelone injection | utidelone monotherapy in patients with advanced NSCLC by utidelone |
Timeline
- Start date
- 2019-04-22
- Primary completion
- 2021-06-25
- Completion
- 2021-08-10
- First posted
- 2018-10-03
- Last updated
- 2023-01-10
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03693547. Inclusion in this directory is not an endorsement.